These findings complement the work of Stanek et al [9] and Bethin et al [10], who found that CGM use was the same among children with T1D and ASD as it was among those with T1D but without ASD, whereas insulin pump use was lower for those with both T1D and ASD. The gene discussed is INS; the disease is type 1 diabetes mellitus.